Don’t wait for the future: be proactive for your patients with T2D now!

Boehringer Ingelheim and Eli Lilly and Company |

Chair: John Buse (USA)

18:00 – 18:05Welcome and introductionJohn Buse (USA)
18:05 – 18:50Discussion between four expertsJohn Buse (USA)

David Cherney (CAN)
Xavier Cos (ESP)
Shelley Zieroth (CAN)

18:50 – 19:00Audience Q&A, summary and closeAll faculty
moderated by John Buse (USA)